MLPA and MAPH: New Techniques for Detection of Gene Deletions

Human Mutation

Volumn 23, Issue 5, 2004, Pages 413-419

  Sellner, Loryn N ^a   Taylor, Graham R ^b  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Deletion; Duplication; Gene dosage; MAPH; MLPA; Mutation detection

Indexed keywords

GENOMIC DNA;

BASE PAIRING; CYTOGENETICS; DIAGNOSTIC ACCURACY; DNA HYBRIDIZATION; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE IDENTIFICATION; GENE LOCATION; GENE LOSS; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; MOLECULAR SIZE; MULTIPLEX AMPLIFICATION AND PROBE HYBRIDIZATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE GENETICS; REVIEW; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; TECHNIQUE;

BASE SEQUENCE; CYTOGENETIC ANALYSIS; DNA MUTATIONAL ANALYSIS; DNA PROBES; GENE DELETION; GENETIC DISEASES, INBORN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MOLECULAR SEQUENCE DATA; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION;

EID: 2342578875     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20035     Document Type: Review

References (22)

1. Armour JA, Sismani C, Patsalis PC, Cross G. 2000. Measurement of locus copy number by hybridisation with amplifiable probes. Nucleic Acids Res 28:605-609.
2. Choi SW, Lee KJ, Bae YA, Min KO, Kwon MS, Kim KM, Rhyu MG. 2002. Genetic classification of colorectal cancer based on chromosome loss and microsatellite instability predicts survival. Clin Cancer Res 8:2311-2322.
3. Favis R, Day JP, Gerry NP, Phelan C, Narod S, Barany F. 2000. Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol 18:561-564.
4. Gad S, Caux-Moncoutier V, Pages-Berhouet S, Gauthier-Villars M, Coupier I, Pujol P, Frenay M, Gilbert B, Maugard C, Bignon YJ, Chevrier A, Rossi A, Firicker JP, Nguyen TD, Demange L, Aurias A, Bensimon A, Stoppa-Lyonnet D. 2002. Significant contribution tion of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21:6841-6847.
5. Gille JJ, Hogervorst FB, Pals G, Wijnen J, Van Schooten RJ, Dommering CJ, Meijer GA, Craanen ME, Nederlof PM, De Jong D, McElgunn CJ, Schouten JP, Menko FH. 2002. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 87:892-897.
6. Harries M, Smith I. 2002. The development and clinical use of trastuzumab (Herceptin). Endocr Relat Cancer 9:75-85.
7. Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, Kluijt I, Dommering C, Verhoef S, Schouten JP, van't Veer LJ, Pals G. 2003. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63:1449-1453.
8. Hollox EJ, Atia T, Cross G, Parkin T, Armour JA. 2002. High throughput screening of human subtelomeric DNA for copy number changes using multiplex amplifiable probe hybridisation (MAPH). J Med Genet 39:790-795.
9. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, Muller CR, Lindlof M, Kaariainen H, de la Chapelle A, Kiuru A, Savontaus ML, Gilgenkrantz H, Recan D, Chelly J, Kaplan JC, Covone AE, Archidiacono N, Romeo G, Liechti-Gallati S, Schneider V, Braga S, Moser H, Darras BT, Murphy P, Francke U, Chen JD, Morgan G, Denton M, Greenberg CR, Wrogemann K, Blonden LAJ, van Paassen HMB, van Ommen GJB, Kunkel LM. 1989. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 45:498-506.
10. Montagna M, Palma MD, Menin C, Agata S, De Nicolo A, Chieco-Bianchi L, D'Andrea E. 2003. Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12:1055-1061.
11. Nagahata T, Hirano A, Utada Y, Tsuchiya S, Takahashi K, Tada T, Makita M, Kasumi F, Akiyama F, Sakamoto G, Nakamura Y, Emi M. 2002. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers. Breast Cancer 9:208-215.
12. Nishida N, Fukuda Y, Komeda T, Ito T, Nishimura T, Minata M, Kuno M, Katsuma H, Ikai I, Yamaoka Y, Nakao K. 2002. Prognostic impact of multiple allelic losses on metastatic recurrence in hepatocellular carcinoma after curative resection. Oncology 62:141-148.
13. Puget N, Stoppa-Lyonnet D, Sinilnikova OM, Pages S, Lynch HT, Lenoir GM, Mazoyer S. 1999. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 59:455-461.
14. Reid AG, Tarpey PS, Nacheva EP. 2003. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes. Genes Chromosomes Cancer 37:282-290.
15. Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, Han L, Panton R, Branco P, Gallie B. 2003. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 72:253-269.
16. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. 2002. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57.
17. Shuin T, Kondo K, Kaneko S, Sakai N, Yao M, Hosaka M, Kanno H, Ito S, Yamamoto I. 1995. Results of mutation analyses of von Hippel-Lindau disease gene in Japanese patients: comparison with results in United States and United Kingdom. Acta Urologica Japonica 41:703-707.
18. Sismani C, Armour JA, Flint J, Girgalli C, Regan R, Patsalis PC. 2001. Screening for subtelomeric chromosome abnormalities in children with idiopathic mental retardation using multiprobe telomeric FISH and the new MAPH telomeric assay. Eur J Hum Genet 9:527-532.
19. Vortmeyer AO, Huang SC, Pack SD, Koch CA, Lubensky IA, Oldfield EH, Zhuang Z. 2002. Somatic point mutation of the wild-type allele detected in tumors of patients with VHL germline deletion. Oncogene 21:1167-1170.
20. Wagner A, Barrows A, Wijnen JT, van der Klift H, Franken PF, Verkuijlen P, Nakagawa H, Geugien M, Jaghmohan-Changur S, Breukel C, Meijers-Heijboer H, Morreau H, van Puijenbroek M, Burn J, Coronel S, Kinarski J, Okimoto R, Watson P, Lynch JF, de la Chapelle A, Lynch HT, Fodde R. 2003. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 72:1088-1100.
21. White S, Kalf M, Liu Q, Villerius M, Engelsma D, Kriek M, Vollebregt E, Bakker B, van Ommen GJ, Breuning MH, den Dunnen JT. 2002. Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridisation. Am J Hum Genet 71:365-374.
22. Wijnen J, van der Klift H, Vasen H, Khan PM, Menko F, Tops C, Meijers-Heijboer H, Lindhout D, Moller P, Fodde R. 1998. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 20:326-328.